Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

BIORA THERAPEUTICS, INC. (PROG)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-KS-1/A
Net income  -247.4-192.5-228.8-0.1
Depreciation and amortization  1.41.44.76.1
Asset impairment charges    0.50.9
Stock-based compensation    2.42.3
Deferred taxes     6.2
Change in working capital   [+]-4.7-56.415.546.2
Other operating activities  110.3154.599.6-126.7
Cash from operations  -140.3-93.0-106.1-65.1
   
Capital expenditures  0.93.9-3.7-4.8
Sales of short-term investments, net   [+]  20.260.7
Other cash from investing  -2.1-8.80.0 
Cash from investing  -1.2-4.916.555.8
   
Cash dividends paid    -4.5 
Issuance of common stock, net  46.8116.40.6-10.8
Other cash from financing  118.3113.377.6-2.0
Cash from financing  165.0229.773.6-12.8
   
Free cash flow  -139.5-89.1-109.8-70.0
        Per share (diluted)  ($1.45)($3.24)($22.50)($15,021.03)
   
Cash paid for interest  7.53.97.57.6
Cash paid for income taxes  0.40.10.00.2

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy